RaySearch Laboratories AB (publ) announces an expansion of the advanced treatment planning system RayStation®* at the Department of Radiation Oncology and Molecular Sciences at The Sidney Kimmel Comprehensive Cancer Center, in Baltimore, US- an NCI-designated Comprehensive Cancer Center. The expansion includes treatment planning system for photons at the center and several partner sites.

The Johns Hopkins Proton Center at Sibley Memorial Hospital has used RayStation for proton therapy treatment planning since it opened. Now Johns Hopkins Medicine is expanding the use of RayStation to include photon therapy planning for all of its partner centers.

Johns Hopkins Medicine is a leading healthcare system headquartered in Baltimore, Maryland, and treats over 3,000  patients annually using photon therapy. The decision to select RayStation will enable Johns Hopkins to consolidate existing systems and standardize treatment planning throughout the enterprise.

The RayStation installation will provide advanced automation and cutting-edge artificial intelligence features, such as deep learning segmentation and machine learning automated planning. Other key RayStation features will include automated breast planning and fallback planning (automated planning for different modalities with backup plan creation), multi-criteria optimization, deformable registration and adaptive therapy.

The agreement provides for an enterprise configuration for five centers in the Baltimore-Washington D.C. region: The Johns Hopkins Hospital, The Kimmel Cancer Center at Johns Hopkins Bayview, The Kimmel Cancer Center at Green Spring Station, The Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital, and The Sidney Kimmel Comprehensive Cancer Center at Suburban Hospital.

RayStation represents the next generation of treatment planning systems and is the market leader in proton planning, offering a superior user experience and groundbreaking features and benefits for radiation oncology teams. These include machine learning, automated planning, support for adaptive therapy, multi-criteria optimization, fast and accurate dose computation, robust optimization, and a comprehensive toolbox that enables physicians to efficiently represent the patient anatomy and easily compare and approve plans.

Johan Löf, founder and CEO, RaySearch, says: "We are very pleased to support Johns Hopkins in its expansion of RayStation, which will bring outstanding benefits to patient treatment and workflow efficiency. We look forward to extending our collaboration with Johns Hopkins across the US."

The order value, excluding service contract, is about 2.9 MUSD, of which the majority will be recognized as revenues within Q4 2020.
 

About Johns Hopkins Medicine
Headquartered in Baltimore, Maryland, Johns Hopkins Medicine unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. Johns Hopkins Medicine has six academic and community hospitals, four suburban health care and surgery centers, over 40 patient care locations, a home care group and an international division, and it offers an array of health care services. 

The Johns Hopkins Hospital is ranked #3 in the US as top hospitals, with the Sidney Kimmel Cancer Center being ranked #4 in the US as top cancer hospitals, according to U.S News and World Report 2020-21 survey. 

About RaySearch
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets worldwide its treatment planning system RayStation and next-generation oncology information system RayCare*. Over 2,600 clinics in more than 65 countries use RaySearch software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003

About RayStation
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide.

* Subject to regulatory clearance in some markets.

More information about RaySearch is available at www.raysearchlabs.com

 
For further information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
johan.lof@raysearchlabs.com

Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59
peter.thysell@raysearchlabs.com

https://news.cision.com/raysearch-laboratories/r/johns-hopkins-medicine-takes-photon-treatment-planning-to-the-next-level-with-raystation,c3264055

https://mb.cision.com/Main/1102/3264055/1356074.pdf

https://news.cision.com/raysearch-laboratories/i/johns-hopkins-medicine,c2865117

(c) 2021 Cision. All rights reserved., source Press Releases - English